October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Ravi Madan: Enzalutamide Monotherapy in the EMBARK Trial Should Be Practice-changing
Jul 11, 2024, 12:34

Ravi Madan: Enzalutamide Monotherapy in the EMBARK Trial Should Be Practice-changing

Ravi Madan, Clinical researcher focused on Prostate Cancer at National Cancer Institute, shared a post on X:  .

Now online. European Urology Oncology: Enzalutamide Monotherapy in EMBARK BCR Prostate Cancer Should Be Practice-changing, and Existing Data Suggest How to Mitigate Toxicity.”

Visit the article website.
Source: Ravi Madan/X

Ravi Madan: Enzalutamide Monotherapy in the EMBARK Trial Should Be Practice-changing